Helena C Lyson1, Anjana E Sharma2, Roy Cherian1, Emily S Patterson3, Kathryn M McDonald4, Shin-Yu Lee5, Urmimala Sarkar1. 1. From the University of California, San Francisco, Division of General Internal Medicine, Center for Vulnerable Populations at Zuckerberg San Francisco General Hospital, San Francisco, California. 2. Department of Family & Community Medicine, University of California, San Francisco, Center for Excellence in Primary Care, San Francisco, California. 3. Division of Health Information Management and Systems, Ohio State University, College of Medicine, School of Health and Rehabilitation Sciences, Columbus, Ohio. 4. Center for Health Policy/Center for Primary Care and Outcomes Research at Stanford University, Stanford. 5. University of California San Francisco, Richard H. Fine People's Clinic at Zuckerberg San Francisco General Hospital, San Francisco, California.
Abstract
OBJECTIVE: The aim of the study was to analyze diverse patients' experiences throughout the medication use process to inform the development of overarching interventions that support safe medication use in community settings. METHODS: Using a qualitative observational approach, we conducted approximately 18 hours of direct observation of the medication use process across multiple settings for a sample of vulnerable, high-risk patients. Observers recorded detailed field notes during the observations. To enrich the observational findings, we also conducted six semistructured interviews with medication safety experts representing a diversity of perspectives. Barriers and facilitators to safe medication use were identified based on inductive coding of the data. RESULTS: A variety of safety vulnerabilities plague all stages of the medication use process and many of the well-established evidence-based interventions aimed at improving the safety of medication use at key stages of the process have not been widely implemented in community settings observed in this study. Key safety vulnerabilities identified include: limited English proficiency, low health literacy, lack of clinician continuity, incomplete medication reconciliation and counseling, unsafe medication storage and disposal habits, and conflicting healthcare agendas with caregivers. CONCLUSIONS: Our findings underscore a need for overarching, comprehensive interventions that span the entire process of medication use, including integrated communication systems between clinicians, pharmacies, and patients, and a "patient navigator" program that assists patients in navigating the entire medication-taking process. Collective ownership of the medication management system and mutual motivation for devising collaborative solutions is needed among key sectors.
OBJECTIVE: The aim of the study was to analyze diverse patients' experiences throughout the medication use process to inform the development of overarching interventions that support safe medication use in community settings. METHODS: Using a qualitative observational approach, we conducted approximately 18 hours of direct observation of the medication use process across multiple settings for a sample of vulnerable, high-risk patients. Observers recorded detailed field notes during the observations. To enrich the observational findings, we also conducted six semistructured interviews with medication safety experts representing a diversity of perspectives. Barriers and facilitators to safe medication use were identified based on inductive coding of the data. RESULTS: A variety of safety vulnerabilities plague all stages of the medication use process and many of the well-established evidence-based interventions aimed at improving the safety of medication use at key stages of the process have not been widely implemented in community settings observed in this study. Key safety vulnerabilities identified include: limited English proficiency, low health literacy, lack of clinician continuity, incomplete medication reconciliation and counseling, unsafe medication storage and disposal habits, and conflicting healthcare agendas with caregivers. CONCLUSIONS: Our findings underscore a need for overarching, comprehensive interventions that span the entire process of medication use, including integrated communication systems between clinicians, pharmacies, and patients, and a "patient navigator" program that assists patients in navigating the entire medication-taking process. Collective ownership of the medication management system and mutual motivation for devising collaborative solutions is needed among key sectors.
Authors: Elizabeth A Flynn; Kenneth N Barker; Ginette A Pepper; David W Bates; Robert L Mikeal Journal: Am J Health Syst Pharm Date: 2002-03-01 Impact factor: 2.637
Authors: Anthony J Avery; Aziz Sheikh; Brian Hurwitz; Lesley Smeaton; Yen-Fu Chen; Rachel Howard; Judy Cantrill; Simon Royal Journal: Br J Gen Pract Date: 2002-10 Impact factor: 5.386
Authors: Jerry H Gurwitz; Terry S Field; Leslie R Harrold; Jeffrey Rothschild; Kristin Debellis; Andrew C Seger; Cynthia Cadoret; Leslie S Fish; Lawrence Garber; Michael Kelleher; David W Bates Journal: JAMA Date: 2003-03-05 Impact factor: 56.272
Authors: Terry C Davis; Michael S Wolf; Pat F Bass; Jason A Thompson; Hugh H Tilson; Marolee Neuberger; Ruth M Parker Journal: Ann Intern Med Date: 2006-11-29 Impact factor: 25.391
Authors: Sarah P Slight; Diane L Seger; Karen C Nanji; Insook Cho; Nivethietha Maniam; Patricia C Dykes; David W Bates Journal: PLoS One Date: 2013-12-26 Impact factor: 3.240